7-146116535-AT-A

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP6BA1

The ENST00000625365.2(CNTNAP2):​c.-229-112delT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0374 in 227,172 control chromosomes in the GnomAD database, including 211 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.030 ( 198 hom., cov: 31)
Exomes 𝑓: 0.051 ( 13 hom. )

Consequence

CNTNAP2
ENST00000625365.2 intron

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: -0.132

Publications

0 publications found
Variant links:
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
  • cortical dysplasia-focal epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP6
Variant 7-146116535-AT-A is Benign according to our data. Variant chr7-146116535-AT-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 359164.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=2, Benign=1}.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0976 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CNTNAP2ENST00000625365.2 linkc.-229-112delT intron_variant Intron 1 of 3 5 ENSP00000485955.1 A0A0D9SES4

Frequencies

GnomAD3 genomes
AF:
0.0296
AC:
4252
AN:
143810
Hom.:
199
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.100
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0110
Gnomad ASJ
AF:
0.000298
Gnomad EAS
AF:
0.00515
Gnomad SAS
AF:
0.00683
Gnomad FIN
AF:
0.00115
Gnomad MID
AF:
0.00345
Gnomad NFE
AF:
0.000597
Gnomad OTH
AF:
0.0236
GnomAD4 exome
AF:
0.0508
AC:
4233
AN:
83302
Hom.:
13
Cov.:
0
AF XY:
0.0492
AC XY:
2096
AN XY:
42628
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.139
AC:
447
AN:
3210
American (AMR)
AF:
0.0577
AC:
205
AN:
3550
Ashkenazi Jewish (ASJ)
AF:
0.0498
AC:
159
AN:
3190
East Asian (EAS)
AF:
0.0481
AC:
339
AN:
7048
South Asian (SAS)
AF:
0.0487
AC:
146
AN:
2996
European-Finnish (FIN)
AF:
0.0426
AC:
202
AN:
4742
Middle Eastern (MID)
AF:
0.0354
AC:
14
AN:
396
European-Non Finnish (NFE)
AF:
0.0463
AC:
2436
AN:
52618
Other (OTH)
AF:
0.0513
AC:
285
AN:
5552
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.286
Heterozygous variant carriers
0
439
878
1317
1756
2195
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0297
AC:
4266
AN:
143870
Hom.:
198
Cov.:
31
AF XY:
0.0299
AC XY:
2092
AN XY:
69878
show subpopulations
African (AFR)
AF:
0.100
AC:
3951
AN:
39436
American (AMR)
AF:
0.0110
AC:
160
AN:
14510
Ashkenazi Jewish (ASJ)
AF:
0.000298
AC:
1
AN:
3360
East Asian (EAS)
AF:
0.00516
AC:
25
AN:
4842
South Asian (SAS)
AF:
0.00708
AC:
32
AN:
4518
European-Finnish (FIN)
AF:
0.00115
AC:
10
AN:
8700
Middle Eastern (MID)
AF:
0.00368
AC:
1
AN:
272
European-Non Finnish (NFE)
AF:
0.000597
AC:
39
AN:
65334
Other (OTH)
AF:
0.0234
AC:
47
AN:
2006
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
189
378
566
755
944
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000669
Hom.:
1
Bravo
AF:
0.0315

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Cortical dysplasia-focal epilepsy syndrome Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Pitt-Hopkins-like syndrome Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Aug 20, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.13
Mutation Taster
=300/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.14
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs886062041; hg19: chr7-145813627; COSMIC: COSV62147084; COSMIC: COSV62147084; API